Fig. 4
From: Added value of diffusion-weighted imaging in hepatic tumors and its impact on patient management
51 year old female patient with hepatic metastases of a neuroendocrine tumor which was only detectable in DWI (white arrow). The simulated tumorboard decided on neoadjuvant chemotherapy.
1) Image series at baseline, 2) Image series after neoadjuvant chemotherapy with progressive disease. a. Diffusion-weighted image (b-value 800). b. Corresponding ADC map. c. T2-weighted sequence. d. T1-weighted post-contrast scan